How Spravato Fits Into Modern Psychiatric Treatment Plans

For a long time, treating depression meant trying antidepressants until something worked. Or didn’t. For people who cycled through multiple medications without improvement, options got limited fast. That’s part of the clinical reality that led to Spravato's approval.Spravato (esketamine) is an FDA-approved nasal spray for adults with treatment-resistant depression. It works through a different brain pathway than standard antidepressants, gets administered in a clinic, and tends to act faster.This podcast explores what that means for psychiatric treatment, how clinicians use it, where it fits within a care plan, and what the experience entails.Visit Zeam Health and Wellness for more information.